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Table 1 (Abstr. M60). MeanRT values per 100,000 cells per day ofviral 
accumulation 
Day Control Poi High Po!Low PurHigh PurLow 
2 3.2E6 3.8E6 4.9E6 13.6E6 13.4E6 
±0.5E6 ± 0.4E6 ±0.9E6 ±0.4E6 ±4.9E6 
4 12.7E6 13.7E6 15.2E6 720.6E6 59.IE6 
±2.7E6 ± 1.5E6 ± l.3E6 ± 341.6E6 ± 21.8E6 
7 8.6E6 13.8E6 17.4E6 527.IE6 21.6E6 
± 1.7E6 ±2.5E6 ± 3.3E6 ± 210. IE6 ±5.9E6 
9 27.9E6 27.7E6 28.4E6 529.4E6 27.4E6 
± 1.8E6 ± l.5E6 ± 6.5E6 ± 104.4E6 ± l.5E6 
13 9.7E6 12.0E6 9.9E6 215.0E6 6.5E6 
± 0.8E6 ± 3.IE6 ±0.9E6 ± 13.5E6 ± 0.8E6 
17 5.2E6 7.0E6 6.4E6 198.6E6 4.2E6 
± l.OE6 ± 1.7E6 ±0.8E6 ± 11.7E6 ±0.3E6 
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Autoaggregation in bacteria is the phenomenon of aggregation between 
cells of the same strain, whereas coaggregation is due to aggregation 
occurring among different species. Aggregation ability of prebiotic 
bacteria is related to adhesion ability, which is a prerequisite for the 
colonization and protection of the gastrointestinal tract in ali animal 
species; however, coaggregation ability of prebiotic bacteria offers a 
possibility of close interaction with pathogenic bacteria. Coaggregation 
ability of cell wall components of Saccharomyces cerevisiae is known, 
because oftheir mannan content, but literature offers little information 
on this topic. The aim of this experiment was to assess the ability of 
coaggregation of2 preparations ofS. cerevisiae cell walls to 3 pathogenic 
bacteria (Staphylococcus aureus hemolytic enterotoxin A, Salmonella 
enteritidis and Escherichia coli serotype 0157:H/7). Cell wall prepa-
rations consisted on either the distillery cream (DT), a byproduct of 
sugar cane, or a hydrolyzate (HT) obtained by enzymatic methods. 
Pathogens were grown in nutritive broth medium for 18 h at 37ºC. 
After that, cultures were diluted (1:1) withDT andHT, and absorbance 
(5601..) was measured at O and 5 h. Both DT and HT showed the ability 
of coaggregate to the 3 pathogenic strains, and no bacteria! strain x cell 
wall preparation interaction (P = 0.379) was detected. Coaggregation 
was higher (P < 0.001; SEM = 0.36) with HT (mean values of 85.3, 
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· 78.6 and 77.8% for S. aureus, S. enteritidis, and E. coli, respectively) 
compared with DT (mean values of16.5, 5.8 and 6.0% forS. aureus, S. 
enterit1dis, andE. coli, respectively). Ifconfirmed with otherpathogen 
species, these results support further research on the use ofthe HT from 
S. cerevisiae as a possible prebiotic additive for animal feed. 
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The aims of this study were to investigate ( 1) the eflicacy of chito san 
in 2 forms, the monomer N-acetyl glucosamine (NAG) and a chloride 
salt of chitosan (MIX) in culture systems HCT-8 and Caco-2 cell lines 
in vitro for C!yptosporidium parvum compared with a positive control, 
paromomycin (PARO) a classical drug used in veterinary medicine; 
(2) the action of a chitosan-yeast-bacteria based product on neonatal 
diarrhea and mortality in goal kids. Cryptosporidiosis is considered 
as an economically importan! disease with clinical signs and death in 
young ruminants. The usual clinical symptom is acule diarrhea affecting 
animals from 1 to 3 weeks old. As no drugs are fully effective in the 
treatment of cryptosporidiosis in man and animals, the research for new 
therapeutic agents is crucial. Chitosan is a sugar that is obtained from 
the hard outer skeleton of shellfish, including crab and shrimp and it 
is used in medicine. It has been found to be active against a variety of 
diseases including anti.J.nicrobial and anti-tumoral effects. Immunofiuo-
rescence teclmique was used for the identification and enumeration of 
the parasites. The results showed a significan! reduction ofviability of 
Cryptosporidium oocysts (>95%) after pre-incubation of24h at 37ºC 
with PARO (P < 0.001), MIX and NAG (P < 0.001). Additionally, 
PARO, MIX and NAG inhibited significantly the development of C. 
parvum in HCT-8 and Caco-2 cell lines (P < 0.005). These effects were 
dose-dependent. Synergistic effects were obtained when NAG treatment 
was associated withParomomycin. The eflicacy ofMIX in combination 
with yeast and bacteria (OptisafFIRST, Phileo, France) was evaluated 
experimentally in goal neonates inoculated with C. parvum oocystes 
(106 oocytes/mL) per oral route. Preliminary results showed a signifi-
can! reduction in oocyst shedding and diarrhea score in goal kids and 
mortality was significantly reduced (36%) in treated anin1als (P < 0.05) 
compared with the control group (90%). In conclusion, these findings 
provide evidence of in vitro inhibitory activities of chitosan against C. 
parvum and its combination with yeast-based products revealed promis-
ing in lessening the incidence of neonatal diarrhea in young ruminants. 
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